| Latest Forum Topics / Healthway Med |
|
|
IFA recommendation
|
|||||
|
newbieinvestor
Member |
28-Mar-2017 09:58
|
||||
|
x 0
x 0 Alert Admin |
Accordingly, as at 5.00 p.m. (Singapore time) on 27 March 2017, the total number of (a) Shares owned, controlled or agreed to be acquired by the Offeror and parties acting or presumed to be acting in concert with it and (b) valid acceptances to the Offer, amount to an aggregate of 772,817,408 Shares, representing approximately  31.41%  of the total number of issued Shares and 28.04% of the maximum potential issued share capital of the Company.  RHBSEC wishes to announce, for and on behalf of the Offeror, that the Closing Date of the Offer is extended from 5.30 p.m. (Singapore time) on 28 March 2017 to 5.30 p.m. (Singapore time) on  2 May 2017  or such later date(s) as may be announced from time to time by or on behalf of the Offeror.  buy share higher than 4.2 cent sure lose money liao. lippo now got 31.41%. he buy the 17% from bankrupt Fan he got 48.41%. he extend offer to 2 May i think can reach higher than 50%. |
||||
| Useful To Me Not Useful To Me | |||||
|
yu2000
Member |
27-Mar-2017 23:54
|
||||
|
x 0
x 0 Alert Admin |
Agree with you.
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
goldminer
Member |
27-Mar-2017 15:25
|
||||
|
x 1
x 0 Alert Admin |
with ref to edge magazine reports, it seems that both gateway n lippo have undervalued the co. ' ' attractive targe for smaller hospitals or new hosiptal chains wanting to set up in Spore, in addition, it is an attractive consolidation target for a clinic chain such as raffles med or q& m dental...going forward, lippo has the ability to create value for shareholders, given its strong expertise in the healthcare aea, it has a reit that can partner with hmc to expand into hospital space, also lippo can provide strong financial backing and cross referencing indonessian clients. so, the future is very bright i think. |
||||
| Useful To Me Not Useful To Me | |||||
|
goldminer
Member |
16-Mar-2017 07:58
|
||||
|
x 0
x 0 Alert Admin |
Interesting enough, post ifa reports the open market price action is telling lippo straight into their face that the offer price is not fair. So maybe it's a matter of time the offer price be revised, if any n to what extents depends on 1)the outcome of the revision of con.loan, or if it's still be there, 2) the commitment of lippo n it's appetite for the level of control it desired, 3)lippo' s financial muscle. Vested n potential investors got to note that as said in the offer documents lippo has no intention to privatise or delist the co, they just want to increase their shares holdings n hv a presence in the lucrative n growing healthcare sectors. They may undertake comprehensive review of the co's operations n inject mgt expertise thereafter. Sounds very positive n promising. Good lucks to those hv faith in the co. 🌞 | ||||
| Useful To Me Not Useful To Me | |||||
|
goldminer
Member |
15-Mar-2017 14:50
|
||||
|
x 0
x 0 Alert Admin |
it' s reasonable to take over the company under such circumstances to safeguard shareholders' value although the over price is not fair.
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
mepkoh
Elite |
15-Mar-2017 11:40
|
||||
|
x 0
x 0 Alert Admin |
it means..it is reasonable to be not fair.. wtf reccomendations..  
|
||||
| Useful To Me Not Useful To Me | |||||
|
goldminer
Member |
15-Mar-2017 11:20
|
||||
|
x 0
x 0 Alert Admin |
The financial terms of the offer are " not fair but reasonable" ... so to accept the offer or sell at higher price in the open market if any.
|
||||
| Useful To Me Not Useful To Me | |||||

